{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:12:21Z","timestamp":1794492741291,"version":"4.9.1"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20210101294JC"],"award-info":[{"award-number":["20210101294JC"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20220204032YY"],"award-info":[{"award-number":["20220204032YY"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115444","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:14:18Z","timestamp":1694794458000},"page":"115444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Progress in the treatment of drug-loaded nanomaterials in renal cell carcinoma"],"prefix":"10.1016","volume":"167","author":[{"given":"Jianyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-2057","authenticated-orcid":false,"given":"Xiaohua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115444_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2023.115444_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euf.2017.02.015","article-title":"Exploratory subgroup analyses of renal function and overall survival in European organization for research and treatment of cancer randomized trial of nephron-sparing surgery versus radical nephrectomy","volume":"3","author":"Scosyrev","year":"2017","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.biopha.2023.115444_bib3","article-title":"Acute coronary syndromes in chronic kidney disease: clinical and therapeutic characteristics","volume":"56","author":"Moisi","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.biopha.2023.115444_bib4","article-title":"Framing cause-effect relationship of acute coronary syndrome in patients with chronic kidney disease","volume":"11","author":"Moisi","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41581-019-0131-x","article-title":"The adjuvant treatment of kidney cancer: a multidisciplinary outlook","volume":"15","author":"Porta","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2023.115444_bib6","article-title":"Renal cell carcinoma with contralateral adrenal metastasis: case report","volume":"49","author":"Paiva","year":"2023","journal-title":"Urol. Case Rep."},{"key":"10.1016\/j.biopha.2023.115444_bib7","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S1470-2045(20)30436-8","article-title":"Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2021.11.022","article-title":"2021 Updated European association of urology guidelines on the use of adjuvant pembrolizumab for renal cell carcinoma","volume":"81","author":"Bedke","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biopha.2023.115444_bib9","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20212051","article-title":"Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment","volume":"42","author":"Chakraborty","year":"2022","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2023.115444_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2023.04.019","article-title":"Renal cell carcinoma of variant histology","author":"Msaouel","year":"2023","journal-title":"Biol. Ther. Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.biopha.2023.115444_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMoa2106391","article-title":"Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma","volume":"385","author":"Choueiri","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.115444_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031685","article-title":"Nanoparticles in clinical translation for cancer therapy","volume":"23","author":"Mundekkad","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114643","article-title":"Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges","volume":"162","author":"Duan","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jiec.2017.06.050","article-title":"Advances in nanomicelles for sustained drug delivery","volume":"55","author":"Amirmahani","year":"2017","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.biopha.2023.115444_bib15","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1021\/acsnano.9b00467","article-title":"Carrier-enhanced anticancer efficacy of sunitinib-loaded green tea-based micellar nanocomplex beyond tumor-targeted delivery","volume":"13","author":"Yongvongsoontorn","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.115444_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235593","article-title":"Promising roles of alternative medicine and plant-based nanotechnology as remedies for urinary tract infections","volume":"25","author":"Chandra","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115444_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/polym12061397","article-title":"Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis","volume":"12","author":"Das","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9030305","article-title":"Advances in nanomaterial-mediated photothermal cancer therapies: toward clinical applications","volume":"9","author":"Han","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.115444_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nano8110923","article-title":"Nano-mediated photodynamic therapy for cancer: enhancement of cancer specificity and therapeutic effects","volume":"8","author":"Mfouo Tynga","year":"2018","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib20","article-title":"Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.4","article-title":"Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition","volume":"6","author":"Nowak-Sliwinska","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115444_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2021.102427","article-title":"Sunitinib with photoirradiation-mediated reactive oxygen species generation induces apoptosis of renal cell carcinoma cells","volume":"35","author":"Yamamoto","year":"2021","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.biopha.2023.115444_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.09.018","article-title":"Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release","volume":"315","author":"Abri Aghdam","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115444_bib24","doi-asserted-by":"crossref","DOI":"10.1063\/5.0047672","article-title":"Nanomaterials for photothermal and photodynamic cancer therapy","volume":"9","author":"Nasseri","year":"2022","journal-title":"Appl. Phys. Rev."},{"key":"10.1016\/j.biopha.2023.115444_bib25","first-page":"1","article-title":"Hyaluronic acid-IR780 nanoparticles for photothermal ablation in orthotopic renal cancer","volume":"2020","author":"Liu","year":"2020","journal-title":"J. Nanomater."},{"key":"10.1016\/j.biopha.2023.115444_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib27","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/ja404985w","article-title":"A core\/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation\/photothermal synergistic therapy","volume":"135","author":"Xiao","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2023.115444_bib28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.610533","article-title":"Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy","volume":"7","author":"Thomas","year":"2020","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.biopha.2023.115444_bib30","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/1061186X.2018.1527337","article-title":"Liposome: composition, characterisation, preparation, and recent innovation in clinical applications","volume":"27","author":"Ahmed","year":"2019","journal-title":"J. Drug Target"},{"key":"10.1016\/j.biopha.2023.115444_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/1061186X.2017.1363209","article-title":"Strategies to release doxorubicin from doxorubicin delivery vehicles","volume":"26","author":"Li","year":"2018","journal-title":"J. Drug Target"},{"key":"10.1016\/j.biopha.2023.115444_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.seminoncol.2004.08.004","article-title":"Liposomal anthracycline treatment for ovarian cancer","volume":"31","author":"Markman","year":"2004","journal-title":"Semin Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.seminoncol.2004.08.003","article-title":"Use of liposomal anthracyclines in Kaposi's sarcoma","volume":"31","author":"Krown","year":"2004","journal-title":"Semin Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1014428720551","article-title":"Phase II trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer","volume":"20","author":"Skubitz","year":"2002","journal-title":"Invest N. Drugs"},{"key":"10.1016\/j.biopha.2023.115444_bib35","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2009.08.004","article-title":"Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer","volume":"30","author":"Malam","year":"2009","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2017.00107","article-title":"Surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach","volume":"7","author":"Shinder","year":"2017","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib37","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.apsb.2020.04.011","article-title":"Remote loading paclitaxel-doxorubicin prodrug into liposomes for cancer combination therapy","volume":"10","author":"Yu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2023.115444_bib38","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.2147\/IJN.S204221","article-title":"Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC","volume":"14","author":"Pal","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.hoc.2023.05.004","article-title":"Role of surgery in metastatic renal cell carcinoma","author":"Nolazco","year":"2023","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.biopha.2023.115444_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"Perez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2023.115444_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrneph.2016.156","article-title":"Nanomedicines for renal disease: current status and future applications","volume":"12","author":"Kamaly","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.biopha.2023.115444_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2012.06.019","article-title":"Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy","volume":"162","author":"Takara","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2023.115444_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/1536012120934957","article-title":"Research progress of radiolabeled Asn-Gly-Arg (NGR) peptides for imaging and therapy","volume":"19","author":"Zhu","year":"2020","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.biopha.2023.115444_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020295","article-title":"Cell penetrating peptides as molecular carriers for anti-cancer agents","volume":"23","author":"Borrelli","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115444_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/IJN.S230879","article-title":"G250 Antigen-targeting drug-loaded nanobubbles combined with ultrasound targeted nanobubble destruction: a potential novel treatment for renal cell carcinoma","volume":"15","author":"Yu","year":"2020","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib46","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41417-020-00271-8","article-title":"Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors","volume":"28","author":"Irenaeus","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.biopha.2023.115444_bib47","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.bmcl.2016.06.085","article-title":"Cationic lioposomes with folic acid as targeting ligand for gene delivery","volume":"26","author":"Cui","year":"2016","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2023.115444_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14712598.2016.1134480","article-title":"Vectors and strategies for nonviral cancer gene therapy","volume":"16","author":"Pahle","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.biopha.2023.115444_bib49","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.biopha.2023.115444_bib50","first-page":"1441","article-title":"Significant induction of apoptosis in renal cell carcinoma cells transfected with cationic multilamellar liposomes containing the human interferon-\u03b2 gene through activation of the intracellular type 1 interferon signal pathway","volume":"40","author":"Takaha","year":"2012","journal-title":"Int J. Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib51","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1208\/s12249-012-9857-5","article-title":"Structure relationship of cationic lipids on gene transfection mediated by cationic liposomes","volume":"13","author":"Paecharoenchai","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2023.115444_bib52","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.7150\/thno.48662","article-title":"Nanomedicine of tyrosine kinase inhibitors","volume":"11","author":"Smidova","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115444_bib53","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.xphs.2017.01.027","article-title":"Focused ultrasound-triggered release of tyrosine kinase inhibitor from thermosensitive liposomes for treatment of renal cell carcinoma","volume":"106","author":"Abshire","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2018.09.010","article-title":"Thermosensitive liposomes for triggered release of cytotoxic proteins","volume":"132","author":"de Matos","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2023.115444_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.02.041","article-title":"Perfluorooctyl bromide & indocyanine green co-loaded nanoliposomes for enhanced multimodal imaging-guided phototherapy","volume":"165","author":"Sheng","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115444_bib56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2014.08.026","article-title":"Modulating cancer multidrug resistance by sertraline in combination with a nanomedicine","volume":"354","author":"Drinberg","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2023.115444_bib57","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cbdd.13652","article-title":"Sertraline\/ICG-loaded liposome for dual-modality imaging and effective chemo-photothermal combination therapy against metastatic clear cell renal cell carcinoma","volume":"95","author":"Lei","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2023.115444_bib58","doi-asserted-by":"crossref","first-page":"509","DOI":"10.18433\/jpps31788","article-title":"Solid lipid nanoparticles: an approach to improve oral drug delivery","volume":"24","author":"Mendoza-Mu\u00f1oz","year":"2021","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119386","article-title":"Fabrication and in vivo evaluation of ligand appended paclitaxel and artemether loaded lipid nanoparticulate systems for the treatment of NSCLC: A nanoparticle assisted combination oncotherapy","volume":"583","author":"Khatri","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119377","article-title":"Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer","volume":"275","author":"Takke","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib61","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-021-03105-y","article-title":"Emerging uses of PLA-PEG copolymer in cancer drug delivery","volume":"12","author":"Mundel","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.biopha.2023.115444_bib62","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.7150\/thno.27828","article-title":"Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics","volume":"8","author":"Ray","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115444_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101046","article-title":"Polymers and inorganic nanoparticles: a winning combination towards assembled nanostructures for cancer imaging and therapy","volume":"36","author":"Yang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2023.115444_bib64","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/21691401.2016.1175444","article-title":"In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562","volume":"45","author":"Hasandoost","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115444_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12291-013-0364-6","article-title":"Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status","volume":"29","author":"Fatemeh","year":"2014","journal-title":"Indian J. Clin. Biochem"},{"key":"10.1016\/j.biopha.2023.115444_bib66","article-title":"Turkish propolis and its nano form can ameliorate the side effects of cisplatin, which is a widely used drug in the treatment of cancer","volume":"9","author":"Tatli Seven","year":"2020","journal-title":"Plants (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ph13030044","article-title":"Preparation, characterization, and evaluation of cisplatin-loaded polybutylcyanoacrylate nanoparticles with improved in vitro and in vivo anticancer activities","volume":"13","author":"Ghaferi","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib68","doi-asserted-by":"crossref","first-page":"12883","DOI":"10.1039\/D1CS00559F","article-title":"Nanoscale porous organic polymers for drug delivery and advanced cancer theranostics","volume":"50","author":"Singh","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biopha.2023.115444_bib69","article-title":"Application of nanomicelles in enhancing bioavailability and biological efficacy of bioactive nutrients","volume":"14","author":"Li","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"Torchilin","year":"2007","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2023.115444_bib71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1049\/nbt2.12018","article-title":"Nanomicelles: types, properties and applications in drug delivery","volume":"15","author":"Bose","year":"2021","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.biopha.2023.115444_bib72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.actbio.2021.10.034","article-title":"A nanotherapeutic strategy to overcome chemoresistance to irinotecan\/7-ethyl-10-hydroxy-camptothecin in colorectal cancer","volume":"137","author":"Huang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2023.115444_bib73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00280-018-3693-6","article-title":"A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients","volume":"82","author":"Hamaguchi","year":"2018","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib74","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1158\/0008-5472.CAN-07-6532","article-title":"Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression","volume":"68","author":"Sumitomo","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115444_bib75","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jconrel.2022.09.033","article-title":"Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: current status and challenges","volume":"351","author":"Ali","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115444_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644718","article-title":"Insight into the prospects for RNAi therapy of cancer","volume":"12","author":"Tian","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib77","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/nat.2020.0882","article-title":"Folate receptor-mediated siRNA delivery: recent developments and future directions for RNAi therapeutics","volume":"31","author":"Gangopadhyay","year":"2021","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.biopha.2023.115444_bib78","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1158\/0008-5472.CAN-12-1645","article-title":"DDX31 regulates the p53-HDM2 pathway and rRNA gene transcription through its interaction with NPM1 in renal cell carcinomas","volume":"72","author":"Fukawa","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2023.115444_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091448","article-title":"B7-H4 immune checkpoint protein affects viability and targeted therapy of renal cancer cells","volume":"11","author":"Emaldi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115444_bib80","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1021\/acs.biomac.7b00937","article-title":"Self-assembled polypeptide nanogels with enzymatically transformable surface as a small interfering RNA delivery platform","volume":"18","author":"Nishimura","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2023.115444_bib81","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/cas.12547","article-title":"Cycloamylose-nanogel drug delivery system-mediated intratumor silencing of the vascular endothelial growth factor regulates neovascularization in tumor microenvironment","volume":"105","author":"Fujii","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib82","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.drudis.2020.11.010","article-title":"Smart nanotheranostic hydrogels for on-demand cancer management","volume":"26","author":"Misra","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2023.115444_bib83","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","article-title":"Metal nanoparticles as a promising technology in targeted cancer treatment","volume":"29","author":"Xu","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115444_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112951","article-title":"Biomedical applications of metallic nanoparticles in cancer: current status and future perspectives","volume":"150","author":"Khursheed","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2023.115444_bib85","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.toxrep.2021.03.014","article-title":"Amelioration of diethylnitrosamine (DEN) induced renal oxidative stress and inflammation by Carissa carandas embedded silver nanoparticles in rodents","volume":"8","author":"Singh","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.biopha.2023.115444_bib86","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12011-022-03126-5","article-title":"Assessment of the antitumor activity of green biosynthesized zinc nanoparticles as therapeutic agent against renal cancer in rats","volume":"201","author":"El-Sonbaty","year":"2023","journal-title":"Biol. Trace Elem. Res"},{"key":"10.1016\/j.biopha.2023.115444_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120915","article-title":"Photoresponsive metallopolymer nanoparticles for cancer theranostics","volume":"275","author":"He","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115444_bib88","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.2174\/1381612825666191216150052","article-title":"A review on cancer therapy based on the photothermal effect of gold nanorod","volume":"25","author":"Xu","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2023.115444_bib89","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bju.13590","article-title":"Nanotechnology combined therapy: tyrosine kinase-bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model","volume":"119","author":"Liu","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.biopha.2023.115444_bib90","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/nano5021004","article-title":"Antitumor activities of metal oxide nanoparticles","volume":"5","author":"Vinardell","year":"2015","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/ma13020279","article-title":"Methods for reducing the toxicity of metal and metal oxide NPs as biomedicine","volume":"13","author":"Dlugosz","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib92","article-title":"Zinc oxide nanoparticles promotes ferroptosis to repress cancer cell survival and inhibits invasion and migration by targeting miR-27a-3p\/YAP axis in renal cell carcinoma","volume":"15","author":"Wang","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.biopha.2023.115444_bib93","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jconrel.2021.05.042","article-title":"Magnetic nanoparticles for cancer theranostics: advances and prospects","volume":"335","author":"Li","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115444_bib94","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/adhm.201500235","article-title":"Active targeting of sorafenib: preparation, characterization, and in vitro testing of drug-loaded magnetic solid lipid nanoparticles","volume":"4","author":"Grillone","year":"2015","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2023.115444_bib95","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11095-012-0679-7","article-title":"Magnetic nanoparticles for cancer diagnosis and therapy","volume":"29","author":"Yigit","year":"2012","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2023.115444_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901058","article-title":"Magnetic nanoparticles in cancer therapy and diagnosis","volume":"9","author":"Farzin","year":"2020","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.biopha.2023.115444_bib97","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/24\/32\/325102","article-title":"Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft","volume":"24","author":"Fan","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biopha.2023.115444_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12100964","article-title":"Microbubbles and nanobubbles with ultrasound for systemic gene delivery","volume":"12","author":"Endo-Takahashi","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115444_bib99","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.2147\/IJN.S164760","article-title":"The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction","volume":"13","author":"Cai","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib100","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.2147\/IJN.S111808","article-title":"Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction","volume":"11","author":"Fan","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib101","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab7040","article-title":"Anti-G250 nanobody-functionalized nanobubbles targeting renal cell carcinoma cells for ultrasound molecular imaging","volume":"31","author":"Yu","year":"2020","journal-title":"Nanotechnology"},{"key":"10.1016\/j.biopha.2023.115444_bib102","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.actbio.2020.03.034","article-title":"Biogenic nanobubbles for effective oxygen delivery and enhanced photodynamic therapy of cancer","volume":"108","author":"Song","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2023.115444_bib103","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/1061186X.2021.1886301","article-title":"Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects","volume":"29","author":"Sajjadi","year":"2021","journal-title":"J. Drug Target"},{"key":"10.1016\/j.biopha.2023.115444_bib104","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/tcr.201800038","article-title":"Carbon nanomaterials for targeted cancer therapy drugs: a critical review","volume":"19","author":"Hosnedlova","year":"2019","journal-title":"Chem. Rec."},{"key":"10.1016\/j.biopha.2023.115444_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.990362","article-title":"Carbon nanomaterials for drug delivery and tissue engineering","volume":"10","author":"Zheng","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.biopha.2023.115444_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802368","article-title":"Clinical applications of carbon nanomaterials in diagnostics and therapy","volume":"30","author":"Loh","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2023.115444_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.111287","article-title":"Smart Milli-capsules manipulated by nIR irradiation for controllable drug delivery in-vivo for renal cell carcinoma and neurodegenerative diseases","volume":"224","author":"Jia","year":"2022","journal-title":"Mater. Des."},{"key":"10.1016\/j.biopha.2023.115444_bib108","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1166\/jbn.2016.2271","article-title":"Aptamer-directed specific drug delivery and magnetic resonance imaging of renal carcinoma cells in vitro and in vivo","volume":"12","author":"Li","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2023.115444_bib109","article-title":"Graphene oxide and reduced graphene oxide: efficient cargo platforms for cancer theranostics","volume":"60","author":"Alemi","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2023.115444_bib110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.msec.2018.08.039","article-title":"Effects of gallic acid biofabricated rGO nanosheets combined with radiofrequency radiation for the treatment of renal cell carcinoma","volume":"93","author":"Jiang","year":"2018","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.biopha.2023.115444_bib111","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1158\/0008-5472.CAN-10-0250","article-title":"Photothermal response of human and murine cancer cells to multiwalled carbon nanotubes after laser irradiation","volume":"70","author":"Fisher","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2023.115444_bib112","doi-asserted-by":"crossref","first-page":"12897","DOI":"10.1073\/pnas.0905195106","article-title":"Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation","volume":"106","author":"Burke","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115444_bib113","first-page":"707","article-title":"Thermal ablation therapeutics based on CN(x) multi-walled nanotubes","volume":"2","author":"Torti","year":"2007","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib114","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1021\/nn200809t","article-title":"Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model","volume":"5","author":"Meng","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.115444_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020152","article-title":"Progress in mesoporous silica nanoparticles as drug delivery agents for cancer treatment","volume":"13","author":"Mohamed Isa","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115444_bib116","article-title":"A. Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier","volume":"76","author":"Ahmed","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2023.115444_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113332","article-title":"The potential of lonidamine in combination with chemotherapy and physical therapy in cancer treatment","volume":"12","author":"Huang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2023.115444_bib118","first-page":"151","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.115444_bib119","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2020.12.005","article-title":"Biomimetic nanoarchitecturing: a disguised attack on cancer cells","volume":"329","author":"Jha","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115444_bib120","article-title":"Biomimetic nanoparticles camouflaged in cancer cell membranes and their applications in cancer theranostics","volume":"9","author":"Jin","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib121","article-title":"Photothermal therapy enhance the anti-mitochondrial metabolism effect of lonidamine to renal cell carcinoma in homologous-targeted nanosystem","volume":"34","author":"Chen","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115444_bib122","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.ijbiomac.2021.11.044","article-title":"Nanocomposite and bio-nanocomposite polymeric materials\/membranes development in energy and medical sector: a review","volume":"193","author":"Karki","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2023.115444_bib123","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1039\/C9RA01029G","article-title":"Biocompatible carbon-doped MoSe(2) nanoparticles as a highly efficient targeted agent for human renal cell carcinoma","volume":"9","author":"Gao","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.115444_bib124","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cjoc.201500339","article-title":"One-pot solvothermal synthesis of TiO2 nanobelt\/graphene composites for selective renal cancer cells destruction","volume":"34","author":"Cheng","year":"2016","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.biopha.2023.115444_bib125","article-title":"Nanomedicine for renal cell carcinoma: imaging, treatment and beyond","volume":"21","author":"Wu","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2023.115444_bib126","article-title":"Advanced nanomaterials for the diagnosis and treatment of renal cell carcinoma","volume":"3","author":"Ji","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"key":"10.1016\/j.biopha.2023.115444_bib127","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115767","article-title":"Multifaceted role of NF-\u03baB in hepatocellular carcinoma therapy: molecular landscape, therapeutic compounds and nanomaterial approaches","volume":"228","author":"Gupta","year":"2023","journal-title":"Environ. Res"},{"key":"10.1016\/j.biopha.2023.115444_bib129","first-page":"164","article-title":"Evaluation of the association of chronic inflammation and cancer: insights and implications","author":"Nigam","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115444_bib130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cac2.12178","article-title":"Advancing to the era of cancer immunotherapy","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun. (Lond. )"},{"key":"10.1016\/j.biopha.2023.115444_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114308","article-title":"Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy","volume":"185","author":"Shang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115444_bib132","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.bjc.6602526","article-title":"Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2\/HER2 peptide-based vaccination construct","volume":"92","author":"Roth","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2023.115444_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121488","article-title":"Oncolytic peptide nanomachine circumvents chemo resistance of renal cell carcinoma","volume":"284","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2023.115444_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120922","article-title":"Renal cell carcinoma management: a step to nano-chemoprevention","volume":"308","author":"Siddiqi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115444_bib135","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/era.11.66","article-title":"Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations","volume":"11","author":"Roos","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.biopha.2023.115444_bib136","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.purol.2017.07.245","article-title":"Ablative therapy in kidney cancer: Indications","volume":"27","author":"Tricard","year":"2017","journal-title":"Prog. Urol."},{"key":"10.1016\/j.biopha.2023.115444_bib137","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/JHC.S106558","article-title":"Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge","volume":"4","author":"Francica","year":"2017","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.biopha.2023.115444_bib138","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1278-3218(00)89098-8","article-title":"Standards, options, and recommendations for radiotherapy of kidney cancer","volume":"4","author":"Beckendorf","year":"2000","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.biopha.2023.115444_bib139","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/fon.16.2","article-title":"Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma","volume":"12","author":"Siva","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2023.115444_bib140","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.nano.2016.04.002","article-title":"Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer","volume":"12","author":"Kulkarni","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115444_bib141","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2014.12.029","article-title":"A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma","volume":"200","author":"Akita","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115444_bib142","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.2147\/IJN.S203222","article-title":"Apoptotic effect of green synthesized gold nanoparticles from Curcuma wenyujin extract against human renal cell carcinoma A498 cells","volume":"14","author":"Liu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115444_bib143","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijbiomac.2022.05.011","article-title":"Preparation, physicochemical characterization, and cytotoxicity of selenium nanoparticles stabilized by Oudemansiella raphanipies polysaccharide","volume":"211","author":"Jiang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2023.115444_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2021.127349","article-title":"Monodispersed magnetographene quantum dot nanocomposites for delivery of silibinin","volume":"628","author":"Takke","year":"2021","journal-title":"Colloids Surf. A: Physicochem. Eng. Asp."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223012428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223012428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:23:20Z","timestamp":1776461000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223012428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":144,"alternative-id":["S0753332223012428"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115444","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress in the treatment of drug-loaded nanomaterials in renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115444"}}